Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1978 Dec;33(6):755–760. doi: 10.1136/thx.33.6.755

The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.

H M Jansen, T H The, G C de Gast, M T Esselink, G Pastoor, N G Orie
PMCID: PMC470974  PMID: 746500

Abstract

Using the indirect ELISA technique, the IgM, IgG, and IgA antibody response to the primary test immunogen Helix pomatia haemocyanin (HPH) was studied in 30 patients with various clinical stages of primary squamous-cell bronchial carcinoma and compared with values obtained in 15 controls matched for sex, age, smoking habit, and presence of chronic bronchitis. Patients with disseminated disease (stage III) showed a significant decrease in IgG and IgA antibody response (P less than 0.001), but IgM antibodies were relatively high and not different from the controls. Although normal IgG and IgA antibody titres were found at the peak response two weeks after immunisation in patients with localised disease (stage I), these antibody titres showed a significantly more rapid decline after serial investigations at eight and 14 weeks after immunisation compared with the controls (P less than 0.001) despite total removal of the tumour burden at c four weeks after immunisation. In-vitro HPH-induced lymphocyte transformation was considerably decreased in state I patients (P less than 0.01) as well as in stage III patients (P less than 0.001). The results suggest that patients with squamous-cell bronchial carcinoma develop impaired T-cell function, which gives rise to a defective antibody response and in-vitro lymphocyte reactivity to the T-cell dependent primary immunogen HPH.

Full text

PDF
755

Images in this article

758Image
on p.758

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson B., Blomgren H. Evidence for a small pool of immunocompetent cells in the mouse thymus. Its role in the humoral antibody response against sheep erythrocytes, bovine serum albumin, ovalbumin and the NIP determinant. Cell Immunol. 1970 Oct;1(4):362–371. doi: 10.1016/0008-8749(70)90014-6. [DOI] [PubMed] [Google Scholar]
  2. Cohen B. H., Diamond E. L., Graves C. G., Kreiss P., Levy D. A., Menkes H. A., Permutt S., Quaskey S., Tockman M. S. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet. 1977 Sep 10;2(8037):523–526. doi: 10.1016/s0140-6736(77)90663-8. [DOI] [PubMed] [Google Scholar]
  3. Dennert G., De Rose M., Allen R. S. Failure of T cells specific for strong histocompatibility antigens to cooperate with B cells for a humoral response. Eur J Immunol. 1977 Jul;7(7):487–492. doi: 10.1002/eji.1830070716. [DOI] [PubMed] [Google Scholar]
  4. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J Immunol. 1972 Jul;109(1):129–135. [PubMed] [Google Scholar]
  5. Evans D. A. Immunology of bronchial carcinoma. Thorax. 1976 Oct;31(5):493–506. doi: 10.1136/thx.31.5.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gast G. C., The T. H., Schraffordt Koops H., Snijder A. M., Huiges H. A. Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation. Clin Exp Immunol. 1976 Mar;23(3):491–498. [PMC free article] [PubMed] [Google Scholar]
  7. Geha R. S., Schneeberger E., Merler E., Rosen F. S. Heterogeneity of "acquired" or common variable agammaglobulinemia. N Engl J Med. 1974 Jul 4;291(1):1–6. doi: 10.1056/NEJM197407042910101. [DOI] [PubMed] [Google Scholar]
  8. Geha R. S., Schneeberger E., Rosen F. S., Merler E. Interaction of human thymus-derived and non-thymus-derived lymphocytes in vitro. Induction of proliferation and antibody synthesis in B lymphocytes by a soluble factor released from antigen-stimulated T lymphocytes. J Exp Med. 1973 Nov 1;138(5):1230–1247. doi: 10.1084/jem.138.5.1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gershon R. K., Mokyr M. B., Mitchell M. S. Activation of suppressor T cells by tumour cells and specific antibody. Nature. 1974 Aug 16;250(467):594–596. doi: 10.1038/250594a0. [DOI] [PubMed] [Google Scholar]
  10. Heber-Katz E., Wilson D. B. Sheep red blood cell-specific helper activity in rat thoracic duct lymphocyte populations positively selected for reactivity to specific strong histocompatibility alloantigens. J Exp Med. 1976 Mar 1;143(3):701–706. doi: 10.1084/jem.143.3.701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  12. Herberman R. B. Cell-mediated immunity to tumor cells. Adv Cancer Res. 1974;19(0):207–263. doi: 10.1016/s0065-230x(08)60055-x. [DOI] [PubMed] [Google Scholar]
  13. Janossy G., Greaves M. Functional analysis of murine and human B lymphocyte subsets. Transplant Rev. 1975;24:177–236. doi: 10.1111/j.1600-065x.1975.tb00169.x. [DOI] [PubMed] [Google Scholar]
  14. Jansen H. M., The T. H., de Gast G. C., Huiges H. A., Esselink M. T., van der Wal A. M., Orie N. G. Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma. Thorax. 1977 Dec;32(6):706–710. doi: 10.1136/thx.32.6.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kamo I., Patel C., Kateley J., Friedman H. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts. J Immunol. 1975 Jun;114(6):1749–1756. [PubMed] [Google Scholar]
  16. Mitchell M. S. Role of "suppressor" T lymphocytes in antibody-induced inhibition of cytophilic antibody receptors. Ann N Y Acad Sci. 1976;276:229–242. doi: 10.1111/j.1749-6632.1976.tb41649.x. [DOI] [PubMed] [Google Scholar]
  17. Moretta L., Webb S. R., Grossi C. E., Lydyard P. M., Cooper M. D. Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG. J Exp Med. 1977 Jul 1;146(1):184–200. doi: 10.1084/jem.146.1.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reinisch C. L., Andrew S. L., Schlossman S. F. Suppressor cell regulation of immune response to tumors: abrogation by adult thymectomy. Proc Natl Acad Sci U S A. 1977 Jul;74(7):2989–2992. doi: 10.1073/pnas.74.7.2989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ruitenberg E. J., Steerenberg P. A., Brosi B. J., Buys J. Reliability of the enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of Trichinella spiralis infections in conventionally raised pigs. J Immunol Methods. 1976;10(1):67–83. doi: 10.1016/0022-1759(76)90008-9. [DOI] [PubMed] [Google Scholar]
  20. Rümke C. L., Bezemer P. D., Kuik D. J. Normal values and least significant differences for differential leukocyte counts. J Chronic Dis. 1975 Dec;28(11-12):661–668. doi: 10.1016/0021-9681(75)90077-6. [DOI] [PubMed] [Google Scholar]
  21. Saal J. G., Rieber E. P., Hadam M., Riethmuller G. Lymphocytes with T-cell markers cooperate with IgG antibodies in the lysis of human tumour cells. Nature. 1977 Jan 13;265(5590):158–160. doi: 10.1038/265158a0. [DOI] [PubMed] [Google Scholar]
  22. de Gast G. C., The T. H., Snijder J. A. The human immune response to alpha-haemocyanin of Helix pomatia. Acta Med Scand. 1973 Oct;194(4):303–309. doi: 10.1111/j.0954-6820.1973.tb19450.x. [DOI] [PubMed] [Google Scholar]
  23. van der Wal A. M., Huizinga E., Orie N. G., Sluiter H. J., de Vries K. Cancer and chronic non-specific lung disease (C.N.S.L.D.). Scand J Respir Dis. 1966;47(3):161–172. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES